D
Dimitrios Panidis
Researcher at Aristotle University of Thessaloniki
Publications - 182
Citations - 6233
Dimitrios Panidis is an academic researcher from Aristotle University of Thessaloniki. The author has contributed to research in topics: Polycystic ovary & Insulin resistance. The author has an hindex of 36, co-authored 179 publications receiving 5611 citations. Previous affiliations of Dimitrios Panidis include University of Crete.
Papers
More filters
Journal ArticleDOI
Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations
M. Geoffrey Hayes,Margrit Urbanek,David A. Ehrmann,Loren L. Armstrong,Ji Young Lee,Ryan Sisk,Tugce Karaderi,Thomas M. Barber,Mark I. McCarthy,Stephen Franks,Cecilia M. Lindgren,Cecilia M. Lindgren,Corrine K. Welt,Evanthia Diamanti-Kandarakis,Dimitrios Panidis,Mark O. Goodarzi,Ricardo Azziz,Yi Zhang,Roland James,Michael Olivier,Ahmed H. Kissebah,Elisabet Stener-Victorin,Richard S. Legro,Andrea Dunaif,Ruben Alvero,Huiman X. Barnhart,Valerie L. Baker,Kurt T. Barnhart,G. Wright Bates,Robert G. Brzyski,Bruce R. Carr,Sandra Ann Carson,Peter R. Casson,Nicholas A. Cataldo,Gregory M. Christman,Christos Coutifaris,Michael P. Diamond,Esther Eisenberg,Gabriella G. Gosman,Linda C. Giudice,Daniel J. Haisenleder,Hao Huang,Stephen A. Krawetz,Scott Lucidi,Peter G. McGovern,Evan R. Myers,John E. Nestler,Dana A. Ohl,Nanette Santoro,William D. Schlaff,Peter J. Snyder,Michael P. Steinkampf,J. C. Trussell,Rebecca S. Usadi,Qingshang Yan,Heping Zhang +55 more
TL;DR: Common genetic susceptibility loci in European ancestry women for the National Institutes of Health PCOS phenotype are identified, which confers the highest risk for metabolic morbidities, as well as reproductive hormone levels, and implicate neuroendocrine changes in disease pathogenesis.
Journal ArticleDOI
Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS
Eleni Kandaraki,Antonis Chatzigeorgiou,Sarantis Livadas,Eleni Palioura,Frangiscos Economou,Michael Koutsilieris,Sotiria Palimeri,Dimitrios Panidis,Evanthia Diamanti-Kandarakis +8 more
TL;DR: Higher BPA levels inPCOS women compared to controls and a statistically significant positive association between androgens and BPA point to a potential role of this endocrine disruptor in PCOS pathophysiology.
Journal ArticleDOI
Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
Athanasia Piouka,Dimitrios Farmakiotis,Ilias Katsikis,Djuro Macut,Spiros Gerou,Dimitrios Panidis +5 more
TL;DR: Comparison of anti-Müllerian hormone levels among obese or overweight and normal-weight women with the four different polycystic ovary syndrome phenotypes and healthy control subjects found differences in circulating AMH levels appear to reflect the severity of the syndrome, but are negatively affected by obesity.
Journal ArticleDOI
Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis
Konstantinos A Toulis,Dimitrios G. Goulis,Dimitrios Farmakiotis,Neoklis A. Georgopoulos,Ilias Katsikis,Basil C. Tarlatzis,Ioannis Papadimas,Dimitrios Panidis +7 more
TL;DR: After controlling for BMI-related effects, adiponectin levels seem to be lower in women with PCOS compared with non-PCOS controls, and low levels of adiponECTin in PCOS are probably related to IR but not to testosterone.
Journal ArticleDOI
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
Evanthia Diamanti-Kandarakis,Thomas Paterakis,Krystallenia I Alexandraki,Christina Piperi,Athanasios Aessopos,Ilias Katsikis,Nikolaos Katsilambros,George Kreatsas,Dimitrios Panidis +8 more
TL;DR: Findings imply the presence of chronic inflammation in women with PCOS, as metformin decreases the levels of plasma inflammatory indices.